Xiaokui Zhang | Chief Scientific Officer
Celularity

Xiaokui Zhang, Chief Scientific Officer, Celularity

Dr. Xiaokui Zhang has 15+ years of experience in leading discovery, research and development in the biopharmaceutical industry to advance research stage programs into early clinical development. She joined Celularity in August 2017 as EVP, Chief Scientific Officer to head Research & Development operations in immuno-oncology and functional regeneration. Her previous roles included Senior Director of Research at Celgene Cellular Therapeutics where she led the development of novel immunotherapy candidates derived from placental progenitor cells and initiated clinical trials. She holds a B.Sc. in Physiology from Nanjing University, Ph.D. in Molecular Cell Biology from the Rockefeller University with further post-doctoral training in the Functional Genomics Department of Novartis Pharmaceuticals.

back to speakers

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.

TO SPONSOR / EXHIBIT

Erica Baeta 
+44 (0)207 092 1152 
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson 
t/ +44 (0)207 092 1150 
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor 
+44 (0)207 092 1257 
issa.mauthoor@terrapinn.com